NCIt definition : A preparation of autologous CD8 T lymphocytes targeting SLC45A2, a melanoma-associated
antigen, with potential immunomodulating and antineoplastic activities. Following
peripheral blood mononuclear cell (PBMC) collection and ex vivo expansion of SLC45A2-specific
cytotoxic T-lymphocytes (CTLs), the autologous CD8 SLC45A2-specific CTLs are re-infused
into the patient, where they target and lyse SLC45A2-expressing tumor cells. While
SLC45A2 is expressed by approximately 80% of cutaneous melanomas, its expression is
limited in mature normal melanocytes, allowing high tumor selectivity and reduced
potential for autoimmune toxicity.;